The ability to identify individuals at risk for cardiovascular disease (CVD) is of paramount importance with respect to both early detection and control. The 'quality' of lipoprotein particles circulating in the blood exerts a significant influence on CVD. One measure of this 'quality' is its density, the gold standard parameter for characterizing the major lipoprotein classes and their subclasses. The long-term goal is to have in place a general method for characterizing lipoprotein subclasses to accurately distinguish between subject groups and controls in a clinical study. The first specific aim is to develop a comprehensive, accurate and reproducible method for measuring a lipoprotein density profile based on sedimentation equilibrium density-gradient ultracentfiugation. Development of an array of secondary lipoprotein density profiling methods is the focus of the second specific aim. Coupled with this project is a method to recover specific lipoprotein subclasses for a more detailed characterization of structural and functional features. The third specific aim has a statistical analysis and a clinical component. Data derived from the lipoprotein density profile are used to classify subjects and controls using modern statistical methods for classification analysis. The analysis will be developed and applied to a clinical study on atherogenic HDL to determine which statistically-significant parameters are contained in the lipoprotein density profile. The methodology developed from the first three specific aims will be applied to the fourth specific aim, a clinical study to identify lipoprotein subclasses associated with in-stent restenosis following implantation of a bare metal stent. Lipoproteins are active participants in cardiovascular disease and health. They are also internal probes of the circulatory system at the molecular level. The delicate in vivo interplay between lipoprotein subclasses is reflected in features of the lipoprotein density profile, the focus of this proposal.

Public Health Relevance

This project is a contribution to identifying those individuals with normal HDL and LDL cholesterol levels who are actually at risk for developing for cardiovascular disease. Using the same methodology, individuals at risk for premature restenosis following coronary stenting will be identified. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL068794-04A2
Application #
7465910
Study Section
Enabling Bioanalytical and Biophysical Technologies Study Section (EBT)
Program Officer
Fleg, Jerome
Project Start
2001-12-01
Project End
2012-03-31
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
4
Fiscal Year
2008
Total Cost
$287,158
Indirect Cost
Name
Texas A&M University
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
078592789
City
College Station
State
TX
Country
United States
Zip Code
77845
McNeal, Catherine J; Chatterjee, Subroto; Hou, Jennifer et al. (2013) Human HDL containing a novel apoC-I isoform induces smooth muscle cell apoptosis. Cardiovasc Res 98:83-93
Moore, D'Vesharronne; McNeal, Catherine; Macfarlane, Ronald (2011) Isoforms of apolipoprotein C-I associated with individuals with coronary artery disease. Biochem Biophys Res Commun 404:1034-8
Larner, Craig D; Henriquez, Ronald R; Johnson, Jeffrey D et al. (2011) Developing high performance lipoprotein density profiling for use in clinical studies relating to cardiovascular disease. Anal Chem 83:8524-30
Storey, Stephen M; Atshaves, Barbara P; McIntosh, Avery L et al. (2010) Effect of sterol carrier protein-2 gene ablation on HDL-mediated cholesterol efflux from cultured primary mouse hepatocytes. Am J Physiol Gastrointest Liver Physiol 299:G244-54
Pohl, John; Chandra, Richa; Corpuz, Goddy et al. (2008) Hypertriglyceridemia and megacystis-microcolon-intestinal hypoperistalsis syndrome. J Pediatr Gastroenterol Nutr 47:507-13
Johnson, Jeffery D; Henriquez, Ronald R; Tichy, Shane E et al. (2007) UC/MALDI-MS analysis of HDL;evidence for density-dependent post-translational modifications. Int J Mass Spectrom 268:227-233
Chandra, Richa; Macfarlane, Ronald D (2006) Remnant lipoprotein density profiling by CsBiEDTA density gradient ultracentrifugation. Anal Chem 78:680-5
Espinosa, I Leticia; McNeal, Catherine J; Macfarlane, Ronald D (2006) Method for lipoprotein(a) density profiling by BiEDTA differential density lipoprotein ultracentrifugation. Anal Chem 78:438-44
Farwig, Zachlyn N; McNeal, Catherine J; Little, Danny et al. (2005) Novel truncated isoforms of constitutive serum amyloid A detected by MALDI mass spectrometry. Biochem Biophys Res Commun 332:352-6
Hosken, Brian D; Cockrill, Steven L; Macfarlane, Ronald D (2005) Metal ion complexes of EDTA: a solute system for density gradient ultracentrifugation analysis of lipoproteins. Anal Chem 77:200-7

Showing the most recent 10 out of 15 publications